Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Pseudomonas aeruginosa is an aerobic Gram-negative rod-shaped bacterium with a comparatively large genome and an impressive genetic capability allowing it to grow in a variety of environments and tolerate a wide range of physical conditions. This biological flexibility enables the P. aeruginosa to cause a broad range of infections in patients with serious underlying medical conditions, and to be a principal cause of health care associated infection worldwide. The clinical manifestations of P. aeruginosa include mostly health care associated infections and community-acquired infections. P. aeruginosa possesses an array of virulence factors that counteract host defence mechanisms. It can directly damage host tissue while utilizing high levels of intrinsic and acquired antimicrobial resistance mechanisms to counter most classes of antibiotics. P. aeruginosa co-regulates multiple resistance mechanisms by perpetually moving targets poses a significant therapeutic challenge. Thus, there is an urgent need for novel approaches in the development of anti-Pseudomonas agents. Here we review the principal infections caused by P. aeruginosa and we discuss novel therapeutic options to tackle antibiotic resistance and treatment of P. aeruginosa infections that may be further developed for clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 2×
“Wisplinghoff et al. [89] published a nation-wide surveillance study on nosocomial BSI in the USA and reported P. aeruginosa as the third most common Gram-negative bacteria causing nosocomial BSI and accounted for 4.3% of all cases.”
BackgroundInfluentialMechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724 · cited 1×
“Hidron et al. [66] ranked P. aeruginosa on 6th position in the report published in 2006–2007 by the National Healthcare Safety Network (NHSN) at the Centers for Disease Control and Prevention (CDC) as the most common hospital-associated pathogen causing infections.”
BackgroundBiofilm, pathogenesis and prevention—a journey to break the wall: a review
Gupta, P., Sarkar, S., Das, B., Bhattacharjee, S., & Tribedi, P. (2016) · Archives of Microbiology · doi:10.1007/s00203-015-1148-6 · Cited by 493
Extracellular DNA as a target for biofilm control
Okshevsky, M., Regina, V. R., & Meyer, R. L. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.12.002 · Cited by 299
Khan, M. S. A., Zahin, M., Hasan, S., Husain, F. M., & Ahmad, I. (2009) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2009.02666.x · Cited by 279 · cited 1×
“Plant essential oils, such as clove oil, were found to inhibit swarming motility and quorum sensing [182–184] .”
BackgroundRaman, G., Avendano, E. E., Chan, J., Merchant, S., & Puzniak, L. (2018) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-018-0370-9 · Cited by 269 · cited 2×
“1 ) compared to other bacteria [4–6] and possesses a great genetic versatility [ 5 , 7 ] which enables it to grow in several different environments, to produce a variety of virulence factors and display antibiotic resistance to the majority of currently available antibiotics [8–13] .”
BackgroundEffect of Human Burn Wound Exudate on Pseudomonas aeruginosa Virulence
Gonzalez, M. R., Fleuchot, B., Lauciello, L., Jafari, P., Applegate, L. A., Raffoul, W., Que, Y.-A., & Perron, K. (2016) · mSphere · doi:10.1128/msphere.00111-15 · Cited by 109 · cited 2×
“Gonzalez et al. [21] conducted a study to monitor the effect of burn wound exudate on growth and expression of virulence factors of P. aeruginosa.”
Background
Metadata
- Authors
- Sathe, N., Beech, P., Croft, L., Suphioglu, C., Kapat, A., & Athan, E.
- Venue
- Infectious Medicine
- Publisher
- Elsevier BV
- Published
- 2023-09
- Volume
- 2
- Issue
- 3
- Pages
- 178-194
- ISSN
- 2097-0684 (ISSN-L)
- 2772-431X
- OpenAlex
- W4378188919
- Cited by
- 160
- References
- 8
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.